Abstract:Recently, an astrocytic aquaporin 4-dependent drainage system, that is, the glymphatic system, has been identified in the live murine and human brain. Growing evidence suggests that glymphatic function is impaired in patients with several neurodegenerative diseases, including Alzheimer's and Parkinson's disease. As the third most common neurodegenerative disease, although animal studies have indicated that early glymphatic dysfunction is likely an important pathological mechanism underpinning amyotrophic lateral sclerosis (ALS), no available study has been conducted to thoroughly assess glymphatic function in vivo in ALS patients to date, particularly in early-stage ALS patients. Thus, using DTI analysis along the perivascular space (ALPS) index, an approximate measure of glymphatic function in vivo, we aimed to explore whether glymphatic function is impaired in early-stage ALS patients and the diagnostic performance of the ALPS index in distinguishing between early-stage ALS patients and healthy subjects. We also aimed to identify the relationships between glymphatic dysfunction and clinical disabilities and sleep problems in early-stage ALS patients. In this retrospective study, King's stage 1 ALS patients were defined as early-stage ALS patients. We enrolled 56 early-stage ALS patients and 32 age- and sex-matched healthy controls (HCs). All participants completed clinical screening, sleep assessment, and ALPS index analysis. For the sleep assessment, the Pittsburgh Sleep Quality Index, Epworth Sleepiness Scale, and polysomnography were used. Compared with HCs, early-stage ALS patients had a significantly lower ALPS index after family-wise error correction (p < 0.05). Moreover, receiver operating characteristic analysis showed that the area under the curve for the ALPS index was 0.792 (95% confidence interval 0.700-0.884). Partial correlation analyses showed that the ALPS index was significantly correlated with clinical disability and sleep disturbances in early-stage ALS patients. Multivariate analysis showed that sleep efficiency (r = 0.419; p = 0.002) and periodic limb movements in sleep index (r = -0.294; p = 0.017) were significant predictive factors of the ALPS index in early-stage ALS patients. In conclusion, our study continues to support an important role for glymphatic dysfunction in ALS pathology, and we provide additional insights into the early diagnostic value of glymphatic dysfunction and its correlation with sleep disturbances in vivo in early-stage ALS patients. Moreover, we suggest that early improvement of glymphatic function may be a promising strategy for slowing the neurodegenerative process in ALS. Future studies are needed to explore the diagnostic and therapeutic value of glymphatic dysfunction in individuals with presymptomatic-stage neurodegenerative diseases.

Symptoms and causes of insomnia in amyotrophic lateral sclerosis

Insomnia is frequent in amyotrophic lateral sclerosis at the time of diagnosis

Sleep disorders in Amyotrophic Lateral Sclerosis

Survey of Factors Influencingsleep Disorder Inpatients with A myotrophic Lateral Sclerosis

Sleep Disturbances in Amyotrophic Lateral Sclerosis and Prognostic Impact—A Retrospective Study

Insomnia in Parkinson's Disease: Causes, Consequences, and Therapeutic Approaches

Pathophysiology and Treatment of Non-motor Dysfunction in Amyotrophic Lateral Sclerosis

Clinical features and progress in diagnosis and treatment of amyotrophic lateral sclerosis

Considerations on the concept, definition, and diagnosis of amyotrophic lateral sclerosis

Amygdala Abnormalities Are Related to Anxiety in Patients with Sporadic Amyotrophic Lateral Sclerosis

The Serotonergic System and Amyotrophic Lateral Sclerosis: A Review of Current Evidence

Amyotrophic Lateral Sclerosis: Molecular Mechanisms, Biomarkers, and Therapeutic Strategies

Hippocampal Subfield and Anterior-Posterior Segment Volumes in Patients with Sporadic Amyotrophic Lateral Sclerosis

Lateral hypothalamus drives early-onset sleep alterations in amyotrophic lateral sclerosis.

Sleep disorders and white matter integrity in patients with sporadic amyotrophic lateral sclerosis

Autophagy and Its Comprehensive Impact on ALS

Hypothalamic Subregion Abnormalities Are Related to Body Mass Index in Patients with Sporadic Amyotrophic Lateral Sclerosis.

Overview of nomenclature and diagnosis of amyotrophic lateral sclerosis

Sleep Disorders Associated with Neurodegenerative Diseases

Risk factors associated with amyotrophic lateral sclerosis based on the observational study: a systematic review and meta-analysis

Glymphatic dysfunction in patients with early-stage amyotrophic lateral sclerosis